Intelligence • Dedication • Experience • Compassion
2008 Office Update
   
Birth Injury
Brain Injury
Cancer
Catastrophic Injury
Children's Malpractice
Defective Medical Devices
HIV and AIDS
Laparoscopic Surgical Errors
Lyme Disease
Medication Errors/Interactions
Medical Malpractice
Mesothelioma and Asbestos
Non-Prescription Toxic Medications
Prescription Medication
Automobile Accidents (Insurance Coverage)
Women's Malpractice
Hospital Infection
Criminal Defense
Emergency Room Errors
Technology in the Courtroom
 
From FDA Safety Information and Adverse Event Reporting Program)

The FDA issued an Early Communication about recent findings of The Data Collection on Adverse Events of Anti-HIV Drugs Study. Data analyses from this study indicate a higher risk of heart attack in patients infected with HIV-1 who were taking Ziagen (abacavir) or Videx(didanosine) as part of their drug therapy. The study is a large observational study of 33, 347 HIV-1 infected patients living in North America , Europe and Australia. Patients in this study are being followed to evaluate the short and long term adverse effects of treatment with anti-HIV drugs. FDA continues to evaluate the overall risks and benefits of abacavir and didanosine. This evaluation may result in the need to revise labeling for the products. Until the FDA's review is complete, health care professionals should evaluate the potential risks and benefits of each HIV-1 antiretroviral drug their patients are taking.

This early communication is in keeping with FDA's commitment to inform the public about its ongoing safety reviews of drugs. As soon as this review is complete, FDA will communicate the conclusions and recommendations to the public.
 

From FDA Safety Information and Adverse Event Reporting Program
The FDA issued an Early Communication about recent findings of The Data Collection on Adverse Events of Anti-HIV Drugs Study. Data analyses from this study indicate a higher risk of heart attack in patients infected with HIV-1 who were taking Ziagen (abacavir) or Videx(didanosine) as part of their drug therapy. Read more...

Patients Receive HIV-Infected Transplants
Four transplant recipients in Chicago contracted HIV from a high-risk donor whose infection went undetected, hospital officials said. Read more...

HIV-positive, but few viruses
Twenty years ago, as the growing AIDS epidemic was sweeping the world, Rod Fichter and a friend got devastating news: They were both HIV-positive. At the time, more than 16,000 Americans a year were dying of AIDS, and no drugs to treat it had been approved. "I really thought it was a death sentence," Fichter said. In fact, in a few years his friend was dead. Read more...

 

Home | Practice Areas | Attorneys | Recent Cases | News Alerts | Testimonials | Contact Us
Legal Links | Questions to Ask | In the Media | Video | Resources | Sitemap

Copyright© 2008 Lewis Law Firm. All rights reserved. Please read our privacy policy.
Web site design and marketing by Legal Internet Solutions Incorporated.

Lewis Law Firm • 936 County Line Road • Bryn Mawr, PA 19010 • (610) 520-7333

free webpage hit counter